A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if SU011248 (sunitinib) provides additional benefit
when it is given after treatment with two chemotherapy drugs carboplatin and paclitaxel and
also if sunitinib is safe for patients with locally advanced and metastatic Non Small Cell
Lung Cancer (NSCLC).